Can gallic acid potentiate the antihyperglycemic effect of acarbose and metformin? Evidence from streptozotocin-induced diabetic rat model

References

• Adefegha, S.A., et al., 2015. Antioxidant and antidiabetic effects of gallic and protocatechuic acids: a structure–function perspective. Comparative clinical pathology, 24 (6), 1579–1585.
   Google Scholar
• Adefegha, S.A., et al., 2016. In vitro antioxidant activities of African birch (Anogeissus leiocarpus) leaf and its effect on the α-amylase and α-glucosidase inhibitory properties of acarbose. Journal of taibah university medical sciences, 11 (3), 236–242.
   Web of Science ®Google Scholar
• Ademiluyi, A.O., and Oboh, G., 2013. Aqeuous Extracts of Roselle (Hibiscus Sabdariffa Linn) varieties inhibit α-amylase and α-glucosidase activities in vitro. Journal of medicinal food, 16 (1), 88–93.
   PubMed Web of Science ®Google Scholar
• Ahad, A., et al., 2015. Gallic acid ameliorates renal functions by inhibiting the activation of p38 MAPK in experimentally induced type 2 diabetic rats and cultured rat proximal tubular epithelial cells. Chemico-biological interactions, 240, 292–303.
   PubMed Web of Science ®Google Scholar
• Alhaider, A.A., et al., 2011. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chemico-biological interactions, 192 (3), 233–242.
   PubMed Web of Science ®Google Scholar
• Alia, M., et al., 2003. Effect of grape antioxidant dietary fiber on the total antioxidant capacity and the activity of liver antioxidant enzymes in rat. Nutrition research, 23, 1251–1267.
   Web of Science ®Google Scholar
• Andrzejewski, S., et al., 2014. Metformin directly acts on mitochondria to alter cellular bioenergetics. Cancer and metabolism, 2 (1), 12.
   PubMedGoogle Scholar
• Aoyama-Sasabe, S., et al., 2016. Insulin secretory defect and insulin resistance in isolated impaired fasting glucose and isolated impaired glucose toleance. Journal of diabetes research, 3, 4.
   Google Scholar
• Apostolidis, E., Kwon, Y. I., and Shetty, K., 2007. Inhibitory potential of herb, fruit, and fungal-enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Innovative food science & emerging technologies, 8 (1), 46–54.
   Google Scholar
• Baba, S.P., and Bhatnagar, A., 2018. Role of thiols in oxidative stress. Current opinion in toxicology, 7, 133–139.
   PubMedGoogle Scholar
• Bajpai, M., et al., 2005. Phenolic contents and antioxidant activity of some food and medicinal plants. International journal of food sciences and nutrition, 56 (4), 287–291.
   PubMed Web of Science ®Google Scholar
• Bak, E.J., et al., 2013. Gallic acid improves glucose tolerance and triglyceride concentration in diet-induced obesity mice. Scandinavian journal of clinical and laboratory investigation, 73 (8), 607–614.
   PubMed Web of Science ®Google Scholar
• Banaszewska, B., et al., 2006. Lipids in polycystic ovary syndrome: Role of hyperinsulinemia and effects of metformin. American journal of obstetrics and gynecology, 194 (5), 1266–1272.
   PubMed Web of Science ®Google Scholar
• Berchtold, L.A., et al., 2016. Cytokines and pancreatic β-Cell Apoptosis. Advances in clinical chemistry, 75, 99–158.
   PubMed Web of Science ®Google Scholar
• Cerf, M.E., 2013. Beta cell dysfunction and insulin resistance. Frontiers endocrinology (Lausanne), 4, 37.
   PubMedGoogle Scholar
• Choubey, S., et al., 2015. Medicinal importance of gallic acid and its ester derivatives: a patent review. Pharmaceutical patent analyst, 4 (4), 305–315.
   PubMed Web of Science ®Google Scholar
• Daglia, M., et al., 2014. Polyphenols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat!. Current pharmaceutical biotechnology, 15 (4), 362–372.,
   PubMed Web of Science ®Google Scholar
• Deconte, S.R., et al., 2011. Alterations of antioxidant biomarkers and type I collagen deposition in the parotid gland of streptozotocin-induced diabetic rats. Archives of oral biology, 56 (8), 744–751.
   PubMed Web of Science ®Google Scholar
• den Besten, G., et al., 2013. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of lipid research, 54 (9), 2325–2340.
   PubMed Web of Science ®Google Scholar
• DiNicolantonio, J.J., Bhutani, J., and O’Keefe, J.H., 2015. Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes. Open heart, 2 (1), e000327.
   PubMed Web of Science ®Google Scholar
• Eboh, A.S., 2014. Biochemistry of free radicals and antioxidants. Scholars academic journal of biosciences, 2 (2), 110–118.
   Google Scholar
• Ellman, G.L., 1959. Tissue sulfhydryl groups. Archives of biochemistry and biophysics, 82 (1), 70–77.
   PubMed Web of Science ®Google Scholar
• Eren, M.A., et al., 2019. The evaluation of thiol/disulphide homeostasis in diabetic nephropathy. Diabetes research and clinical practice, 148, 249–253.
   PubMed Web of Science ®Google Scholar
• Fang, Y., et al., 2002. Free radicals, antioxidants, and nutrition. Nutrition, 18 (10), 872–879.
   PubMed Web of Science ®Google Scholar
• Ferrannini, E., 2014. The target of metformin in type 2 diabetes. New England journal of medicine, 371 (16), 1547–1548.
   PubMed Web of Science ®Google Scholar
• Figueiredo-González, M., et al., 2016. α-Glucosidase and α-amylase inhibitors from Myrcia spp.: a stronger alternative to acarbose? Journal of pharmaceutical and biomedical analysis, 118, 322–327.
   PubMed Web of Science ®Google Scholar
• Fontaine, E., 2018. Metformin-induced mitochondrial complex inhibition: facts, uncertainties, and consequences. Frontier endocrinology (Lausanne), 9, 753.
   PubMed Web of Science ®Google Scholar
• Furman, B.L., 2015. Streptozotocin-induced diabetic models in mice and rats. Current protocols in pharmacology, 70 (1), 5–47.
   PubMedGoogle Scholar
• Gandhi, G.R., et al., 2014. Gallic acid attenuates high-fat diet fed-streptozotocin-induced insulin resistance via partial agonism of PPARγ in experimental type 2 diabetic rats and rats and enhances glucose uptake through translocation and activation of GLUT4 in PI3K/p-Akt signaling pathway. European journal of pharmacology, 15, 745–201.
   Google Scholar
• Gao, J., et al., 2013. Combined effects of green tea extracts, green tea polyphenols or epigallocatechin gallate with acarbose on inhibition against α-amylase and α-glucosidase in vitro. Molecules, 18 (9), 11614–11623.
   PubMed Web of Science ®Google Scholar
• Gerber, P.A., and Rutter, G.A., 2017. The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus. Antioxidants and redox signaling, 26 (10), 501–518.
   PubMed Web of Science ®Google Scholar
• González, E., et al., 2002. Streptozotocin-pancreatic damage in the rat: modulatory effect of 15-deoxy delta12,14-prostaglandin j(2) on nitridergic and prostanoid pathway. Nitric oxide, 6 (2), 214–220.,
   PubMed Web of Science ®Google Scholar
• Gu, Y., et al., 2017. Analyses of gut microbiota and plasma bile acids enable stratification of patients for antidiabetic treatment. Nature communications, 8 (1), 1785.
   PubMed Web of Science ®Google Scholar
• Hasanein, P., and Shahidi, S., 2011. Effects of Hypericum perforatum extract on diabetes-induced learning and memory impairment in rats. Phytotherapy research, 25 (4), 544–549.
   PubMed Web of Science ®Google Scholar
• Hayashi, I., et al., 2007. High-throughput spectrophotometric assay of reactive oxygen species in serum. Mutation research/genetic toxicology and environmental mutagenesis, 631 (1), 55–61.
   PubMed Web of Science ®Google Scholar
• Heikal, A.A., 2010. Intracellular coenzymes as natural biomarkers for metabolic activities and mitochondrial anomalies. Biomarkers in medicine, 4 (2), 241–263.
   PubMed Web of Science ®Google Scholar
• Huang, D.W., et al., 2016. Gallic acid ameliorates hyperglycemia and improves hepatic carbohydrate metabolism in rats fed a high-fructose diet. Nutrition research, 36 (2), 150–160.
   PubMed Web of Science ®Google Scholar
• Huo, J., et al., 2017. Inhibitory effect and mechanism of metformin on human ovarian cancer cells Skov-3 and A2780. European review for medical and pharmacology sciences, 21, 484–489.
   PubMed Web of Science ®Google Scholar
• Ighodaro, O.M., and Akiloye, O.A., 2018. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alexandria journal of medicine, 54 (4), 287–293.
   Web of Science ®Google Scholar
• International Diabetes Federation. 2017. IDF diabetes atlas 8th edition. IDF [online]. Available from: http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf [Accessed 13 January 2020].
   Google Scholar
• Jimoh, T.O., 2018. Enzymes inhibitory and radical scavenging potentials of two selected tropical vegetables (Moringa oleifera and Telfairia occidentalis) leaves relevant to type 2 diabetes mellitus. Revista brasileira de farmacognosia, 28 (1), 73–79.
   Google Scholar
• Kahkeshani, N., et al., 2019. Pharmacological effects of gallic acid in health and diseases: A mechanistic review. Iranian journal of basic medical sciences, 22 (3), 225–237.
   PubMed Web of Science ®Google Scholar
• Karg ulewicz, A., et al., 2016. Improvement of serum adiponectin and leptin concentrations: effects of a low-calorie or isocaloric diet combined with metformin or orlistat – a prospective randomized open-label trial. European review for medical and pharmacology sciences, 20, 3868–3876.
   PubMed Web of Science ®Google Scholar
• Kaul, K., Apostolopoulou, M., and Roden, M., 2015. Insulin resistance in type 1 diabetes mellitus. Metabolism, 64 (12), 1629–1639.
   PubMed Web of Science ®Google Scholar
• Kim, J.H., et al., 2011. Quercetin attenuates fasting and postprandial hyperglycemia in animal models of diabetes mellitus. Nutrition research and practice, 5 (2), 107–111.
   PubMed Web of Science ®Google Scholar
• King, A., and Austin, A., 2017. Animal models of type 1 and type 2 diabetes mellitus. Animal models for the study of human disease, 166 (3), 245–265.
   Google Scholar
• Kumar, M., Thapliyal, M., and Singh, A., 2016. Isolation and Identification of α-Amylase activity inhibitory compounds from Bryophyllum pinnatum. International research journal of biological science, 5 (10), 21–27.
   Google Scholar
• Laoufi, H., et al., 2017. In vitro α-amylase and α-glucosidase inhibitory activity of Ononis angustissima extracts. Journal of applied pharmaceutical science, 7 (02), 191–198.
   Google Scholar
• Liu, B., 2007. Antidiabetic effects of chitooligosaccharides on pancreatic islet cells in streptozotocin-induced diabetic rats. World journal of gastroenterology, 13 (5), 725.
   PubMed Web of Science ®Google Scholar
• Liu, R., et al., 2019. Combination of honey with metformin enhances glucose metabolism and meliorates hepatic and nephritic dysfunction in STZ-Induced diabetic mice. Food and function, 10, 7576–7587.
   PubMed Web of Science ®Google Scholar
• Locatelli, C., Filippin-Monteiro, F.B., and Creczynski-Pasa, T.B., 2013. Alkyl esters of gallic acid as anticancer agents: a review. European journal of medicinal chemistry, 60, 233–239.
   PubMed Web of Science ®Google Scholar
• Lowry, O.H., et al., 1951. Protein measurements with the Folin’s reagent. The journal of biological chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• Madiraju, A.K., et al., 2018. Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. Nature medicine, 24 (9), 1384–1394.
   PubMed Web of Science ®Google Scholar
• Martinez-Gonzalez, A.I., et al., 2017. Polyphenolic compounds and digestive enzymes: in vitro non-covalent interactions. Molecules, 22 (4), 669.,
   Web of Science ®Google Scholar
• Miller, R.A., et al., 2013. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature, 494 (7436), 256–260.,
   PubMed Web of Science ®Google Scholar
• Mitić, M.N., et al., 2010. Antioxidant capacities and phenolic levels of different varieties of Serbian white wines. Molecules, 15 (3), 2016–2027.,
   PubMed Web of Science ®Google Scholar
• Mohan, S., Eskandari, R., and Pinto, B.M., 2014. Naturally occurring sulfonium-ion glucosidase inhibitors and their derivatives: a promising class of potential antidiabetic agents. Accounts of chemical research, 47 (1), 211–225.
   PubMed Web of Science ®Google Scholar
• Nna, V.U., et al., 2018. Antioxidant, anti-inflammatory and synergistic anti-hyperglycemic effects of Malaysian propolis and metformin in streptozotocin–induced diabetic rats. Food and chemical toxicology, 120, 305–320.
   PubMed Web of Science ®Google Scholar
• Oboh, G., et al., 2015. Caffeic and chlorogenic acids inhibit key enzymes linked to type-2 diabetes (in vitro): a comparative study. Journal of basic clinical physiology and pharmacology, 26, 165–170.
   PubMedGoogle Scholar
• Oboh, G., et al., 2016. Influence of gallic acid on α-amylase and α-glucosidase inhibitory properties of acarbose. Journal of food and drug analysis, 24 (3), 627–634.
   PubMed Web of Science ®Google Scholar
• Oboh, G., et al., 2018. Moringa oleifera supplemented diet modulates nootropic-related biomolecules in the brain of STZ-induced diabetic rats treated with acarbose. Metabolic brain disease, 33 (2), 457–466.
   PubMed Web of Science ®Google Scholar
• Oboh, G., et al., 2019. Influence of gallic and tannic acid on therapeutic properties of acarbose in vitro and in vivo in Drosophila melanogaster. Biomedical journal, 42 (5), 317–327.,
   PubMed Web of Science ®Google Scholar
• Ogunsuyi, O.B., Adeoyo, O.O., and Oboh G, 2017. Food-drug interactions: new paradigm in therapeutic potentials of functional foods. In: Oboh G., eds. Functional foods: unlocing the medicine in foods. Akure: Graceland Prints, 199–207.
   Google Scholar
• Ohkawa, H., Ohishi, N., and Yagi, K., 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry, 95 (2), 351–358.
   PubMed Web of Science ®Google Scholar
• Pantidos, N., et al., 2014. Phenolic-rich extracts from the edible seaweed, Ascophyllum nodosum, inhibit α-amylase and α-glucosidase: potential anti-hyperglycemic effects. Journal of functional foods, 10, 201–209.
   Web of Science ®Google Scholar
• Patel, S.S., and Goyal, R.K., 2011. Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats. Pharmacognosy research, 3 (4), 239.
   PubMedGoogle Scholar
• Pernicova, I., and Korbonits, M., 2014. Metformin mode of action and clinical implications for diabetes and cancer. Nature reviews endocrinology, 10 (3), 143–156.
   PubMed Web of Science ®Google Scholar
• Philipp, A.G., and Guy, A.R., 2017. The role of oxidative stress and hypoxia in pancreatic beta-cell dysfunction in diabetes mellitus. Antioxidants and redox signaling, 26, 10.
   Web of Science ®Google Scholar
• Phillips, P., et al., 2003. Acarbose improves glycemic control in overweight type 2 diabetic patients insufficiently treated with metformin. Diabetes care, 26 (2), 269–273.
   PubMed Web of Science ®Google Scholar
• Rameshwar, J., and Anand, K., 2006. Antihyperglycaemic and antiperoxidative roles of acarbose in type 2 diabetes mellitus are possibly mediated through changes in thyroid function. Clinical and experimental pharmacology and physiology, 33 (11), 1104–1106.
   PubMed Web of Science ®Google Scholar
• Rena, G., Hardie, D.G., and Pearson, E.R., 2017. The mechanisms of action of metformin. Diabetologia, 60 (9), 1577–1585.
   PubMed Web of Science ®Google Scholar
• Rhabasa-Lhoret, R., and Chiasson, J.L., 2004. Alpha-glucosiase inhibition In: R.A. Defronzo, E. Ferrannini, H. Keen, and P. Zimmet, eds. International text book of diabetes mellitus, 3rd ed. UK: John Wiley. Vol. 1, 901–914.
   Google Scholar
• Rosak, C., and Mertes, G., 2012. Critical evaluation of the role of acarbose in the treatment of diabetes: patient consideration. Diabetes, metabolic syndrome and obesity, 5, 357–367.
   PubMedGoogle Scholar
• Sankaranarayanan, C., Nishanthi, R., and Pugalendi, P., 2018. Ameliorating effect of berbamine on hepatic key enzymes of carbohydrate metabolism in high-fat diet and streptozotocin induced type 2 diabetic rats. Biomedicine and pharmacotherapy, 103, 539–545.
   PubMed Web of Science ®Google Scholar
• Shahidi, F., Wanasundara, U.N., and Amarowicz, R., 1994. Natural antioxidants from low pungency mustard flour. Food research international, 27 (5), 489–493.
   Web of Science ®Google Scholar
• Shahrad, S., et al., 2001. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. Journal of nutrition, 131 (4), 1207–1210.
   PubMed Web of Science ®Google Scholar
• Shai, L. J., et al., 2010. Yeast alpha glucosidase inhibitory and antioxidant activities of six medicinal plants collected in Phalaborwa, South Africa. South African journal of botany, 76 (3), 465–470.
   Google Scholar
• Shanik, M.H., et al., 2008. Insulin resistance and hyperinsulinemia. Diabetes care, 31 (Supplement 2), S262–S268.
   PubMed Web of Science ®Google Scholar
• Shu, X.S., et al., 2009. Antihyperglycemic effects of total flavonoids from Polygonatum odoratum in STZ and alloxan-induced diabetic rats. Journal of ethnopharmacology, 124 (3), 539–543.
   PubMed Web of Science ®Google Scholar
• Sinha, A.K., 1972. Colorimetric assay of catalase. Analytical biochemistry, 47 (2), 389–394.
   PubMed Web of Science ®Google Scholar
• Swislocki, A., Lardinois, C.K., and Starich, G.H., 2007. Acarbose attenuates basal and postprandial insulin concentrations but fails to lower blood pressure in the spontaneously hypertensive rat. Metabolic syndrome and related disorders, 5 (4), 297–304.
   PubMedGoogle Scholar
• Tan, J., et al., 2014. Chapter Three – the role of short-chain fatty acids in health and disease. Advances in immunology, 121, 91–119.
   PubMed Web of Science ®Google Scholar
• Ullah, A., Khan, A., and Khan, I., 2016. Diabetes mellitus and oxidative stress. A concise review. Saudi pharmaceutical journal, 24, 547–553.
   PubMed Web of Science ®Google Scholar
• Vallejo, S., et al., Sánchez-Ferrer, C.F., 2000. Treatment with acarbose may improve endothelial dysfunction in streptozotocin-induced diabetic rats. Journal of cardiovascular pharmacology, 36 (2), 255–262.
   PubMed Web of Science ®Google Scholar
• Volpe, C.M.O., et al., 2018. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell death and disease nature review, 9, 119.
   PubMed Web of Science ®Google Scholar
• Wang, L., et al., 2014. A systematic review and meta-analysis of acarbose in the treatment of polycystic ovary Syndrome. Journal of endocrine disorders, 1 (3), 1013.
   Google Scholar
• Worthington, V., 1993. Alpha amylase Worthington enzyme manual. Lakewood, NJ: Worthington Biochemical Corporation. 36–41.
   Google Scholar
• World Health Organization (WHO). 2016. Global report on diabetes. Geneva: World Health Organization.
   Google Scholar
• Wu, H., et al., 2017. Metformin alters the gut microbiome of individuals with treatment-naive type -2 diabetes, contributing to the therapeutic effects of the drug. Nature medicine, 23 (7), 850–858.
   PubMed Web of Science ®Google Scholar
• Zhang, B., et al., 2017. Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: structure-activity relationships and the synergism with acarbose. Bioorganic and medicinal chemistry letters, 27 (22), 5065–5070.
   PubMed Web of Science ®Google Scholar
• Zhang, D., et al., 2009. Research on the chemical constituents of Pu-erh tea and its inhibition effect on α-amylase. Southwest China journal of agricultural sciences, 22 (1), 52–54.
   Google Scholar